Skip to main content
BEAT
NASDAQ Life Sciences

Q3 Net Loss Narrows to $3.0M as HeartBeam Cuts Cash Burn and Extends Runway Into 2027

Tom Rudovsky · Reported by BusinessWire
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.405
Mkt Cap
$22.838M
52W Low
$0.355
52W High
$4
52W Position info
14% above low
Off High info
90% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

BEAT is trading near its 52-week low of $0.355 (14% above the low) on light trading volume (0.1× avg).

Summary

HeartBeam reported a Q3 2026 net loss of $3.0 million, or $(0.05) per share, versus $5.3 million, or $(0.15) per share, a year earlier, as total operating expenses fell to $3.5 million from $5.3 million. Cash stood at $6.1 million on September 30; including roughly $4.0 million raised through the ATM in Q4, pro forma cash is about $10.1 million. Management narrowed full-year 2026 operating cash outflow guidance to $12.0-$12.5 million and expects the runway to extend further into 2027. The company is now fully focused on heart attack assessment: it has FDA Breakthrough Device Designation, TAP acceptance, and alignment on a 510(k) pathway, with the U.S. pivotal study design due in Q4 2026 and enrollment starting Q1 2027. The cash position remains thin relative to the pivotal study ahead, so the ATM remains the funding lever to watch.

At the time of this announcement, BEAT was trading at $0.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.8M. The 52-week trading range was $0.36 to $4.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

BEAT - Latest Insights

BEAT
Nov 12, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3969
Real-time Price: $0.4001 info
Change: +$0.0032 (+0.81%) info
Market Cap: $22.748M info
BEAT
Nov 02, 2026, 8:31 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.5402
Real-time Price: $0.4001 info
Change: -$0.1401 (-26%) info
Market Cap: $22.748M info
BEAT
Oct 26, 2026, 8:38 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.4061
Real-time Price: $0.4001 info
Change: -$0.0060 (-1%) info
Market Cap: $22.748M info
BEAT
Oct 05, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $0.697014
Real-time Price: $0.4001 info
Change: -$0.296914 (-43%) info
Market Cap: $22.748M info
BEAT
Oct 05, 2026, 8:31 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $0.4154
Real-time Price: $0.4001 info
Change: -$0.0153 (-4%) info
Market Cap: $22.748M info